Planetary raised $8.1 million in a seed funding round led by Astanor Ventures and followed on by XAnge, Blue Horizon, Nucleus Capital.

Planetary, a Geneva, Switzerland-based biotech company developing alternative food fermentation-based proteins, announced completing a seed funding round closed at $8.1 million.

The money was raised from investors led by Belgium-based VC Astanor Ventures, and joined by XAnge, Blue Horizon and Nucleus Capital.

The proceeds will be used as the company plans include having multiple microbial fermenters capable of producing between 200,000 liters and 500,000 liters of product. The company aims to make that capacity size available for originators and brands so they can go straight into a market without having to have a local presence.

Planetary, founded in 2022 by CEO David Brandes and Marison Ian, is a manufacturing partner (CDMO - Contract Development and Manufacturing Organization) for the production of fermented food products from mycoprotein to speciality proteins and metabolites. The company is building bioprocessing, downstream and formulations at large scale and is primarily working with fermentation companies, those using biomass and precision fermentation techniques to create meat and dairy alternatives.